Inactivation of AKT/NF‑κB signaling by eurycomalactone decreases human NSCLC cell viability and improves the chemosensitivity to cisplatinNahathai Dukaew, Ariyaphong Wongnoppavich|Oncology Reports|2020Cited by 15